{"id":7268,"date":"2012-04-22T15:54:40","date_gmt":"2012-04-22T15:54:40","guid":{"rendered":"http:\/\/cardiophile.org\/?p=7268"},"modified":"2012-04-22T15:54:40","modified_gmt":"2012-04-22T15:54:40","slug":"af-ablation-during-therapeutic-warfarin-levels","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/","title":{"rendered":"AF ablation during therapeutic warfarin levels"},"content":{"rendered":"<h2><span style=\"color: #008000;\">AF ablation during therapeutic warfarin levels<\/span><\/h2>\n<p>AF ablation during therapeutic warfarin levels: Conventionally, invasive procedures are undertaken by switching over from warfarin to unfractionated heparin to have a better control over bleeding. Pasquale Santangeli, Luigi Di Biase, Rodney Horton, J David Burkhardt, Javier Sanchez, Amin Al-Ahmad, Richard Hongo, Salwa Beheiry, Rong Bai, Prasant Mohanty, William R Lewis and Andrea Natale [1]\u00a0have conducted a meta analysis of published data on the utility of proceeding with atrial fibrillation (AF) ablation while on therapeutic anticoagulation with warfarin. This was prompted by data from observational studies which had suggested that procedures under continuous warfarin usage may reduce the risk of periprocedural complications like thromboembolic events compared to the discontinuation of warfarin and bridging with heparin. They could identify nine studies with a total of over twenty seven thousand patients in which six thousand and four hundred had undergone AF ablation with continuous warfarin regimen. Continuous warfarin usage was associated with a significant decrease in thromboembolic complications (odds ratio = 0.10, P &lt; 0.001) and minor bleeding complications (odds ratio = 0.38, P = 0.002) as compared to discontinuation of warfarin and bridging with heparin. This would call for a large randomized controlled trial to evaluate this concept further.<\/p>\n<div><span style=\"color: #0000ff;\"><strong>Reference<\/strong><\/span><\/div>\n<ol>\n<li>Pasquale Santangeli, Luigi Di Biase, Rodney Horton, J David Burkhardt, Javier Sanchez, Amin Al-Ahmad, Richard Hongo, Salwa Beheiry, Rong Bai, Prasant Mohanty, William R Lewis, Andrea Natale. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22271713\">Ablation of Atrial Fibrillation under Therapeutic Warfarin Reduces Periprocedural Complications: Evidence from a Meta-Analysis.<\/a>\u00a0Circ Arrhythm Electrophysiol. 2012;5:302-11.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>AF ablation on therapeutic anticoagulation is being studied more often with an end point of less thromboembolism and acceptable bleeding risk. <\/p>\n","protected":false},"author":1,"featured_media":39409,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-7268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ecg-electrophysiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AF ablation during therapeutic warfarin levels<\/title>\n<meta name=\"description\" content=\"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AF ablation during therapeutic warfarin levels\" \/>\n<meta property=\"og:description\" content=\"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-22T15:54:40+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"AF ablation during therapeutic warfarin levels\",\"datePublished\":\"2012-04-22T15:54:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/\"},\"wordCount\":249,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"ECG \\\/ Electrophysiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/\",\"name\":\"AF ablation during therapeutic warfarin levels\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2012-04-22T15:54:40+00:00\",\"description\":\"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/af-ablation-during-therapeutic-warfarin-levels\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AF ablation during therapeutic warfarin levels\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AF ablation during therapeutic warfarin levels","description":"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/","og_locale":"en_US","og_type":"article","og_title":"AF ablation during therapeutic warfarin levels","og_description":"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.","og_url":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2012-04-22T15:54:40+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"AF ablation during therapeutic warfarin levels","datePublished":"2012-04-22T15:54:40+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/"},"wordCount":249,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#primaryimage"},"thumbnailUrl":"","articleSection":["ECG \/ Electrophysiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/","url":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/","name":"AF ablation during therapeutic warfarin levels","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#primaryimage"},"thumbnailUrl":"","datePublished":"2012-04-22T15:54:40+00:00","description":"AF ablation during therapeutic warfarin levels is being studied more often with an end point of less thromboembolism and acceptable bleeding risk.","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/af-ablation-during-therapeutic-warfarin-levels\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"AF ablation during therapeutic warfarin levels"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/7268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=7268"}],"version-history":[{"count":0,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/7268\/revisions"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=7268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=7268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=7268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}